indolepropionic acid has been researched along with Inflammation in 6 studies
indolepropionic acid: structure in third source
3-(1H-indol-3-yl)propanoic acid : An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have indicated that indolepropionic acid (IPA), derived from dietary tryptophan via gut microbiota conversion, is negatively correlated with type 2 diabetes mellitus and systemic low-grade inflammation." | 8.12 | Indolepropionic acid reduces obesity-induced metabolic dysfunction through colonic barrier restoration mediated via tuft cell-derived IL-25. ( Chen, L; Ji, M; Li, C; Li, M; Liu, W; Liu, Y; Pan, C; Sun, S; Xie, Y; Xu, Z; Yang, Y, 2022) |
| "Previous studies have indicated that indolepropionic acid (IPA), derived from dietary tryptophan via gut microbiota conversion, is negatively correlated with type 2 diabetes mellitus and systemic low-grade inflammation." | 4.12 | Indolepropionic acid reduces obesity-induced metabolic dysfunction through colonic barrier restoration mediated via tuft cell-derived IL-25. ( Chen, L; Ji, M; Li, C; Li, M; Liu, W; Liu, Y; Pan, C; Sun, S; Xie, Y; Xu, Z; Yang, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Owumi, SE | 1 |
| Otunla, MT | 1 |
| Arunsi, UO | 1 |
| Najophe, ES | 1 |
| Du, L | 1 |
| Qi, R | 1 |
| Wang, J | 1 |
| Liu, Z | 1 |
| Wu, Z | 1 |
| Chen, L | 1 |
| Yang, Y | 1 |
| Sun, S | 1 |
| Xie, Y | 1 |
| Pan, C | 1 |
| Li, M | 1 |
| Li, C | 1 |
| Liu, Y | 1 |
| Xu, Z | 1 |
| Liu, W | 1 |
| Ji, M | 1 |
| Tuomainen, M | 1 |
| Lindström, J | 1 |
| Lehtonen, M | 1 |
| Auriola, S | 1 |
| Pihlajamäki, J | 1 |
| Peltonen, M | 1 |
| Tuomilehto, J | 1 |
| Uusitupa, M | 1 |
| de Mello, VD | 1 |
| Hanhineva, K | 1 |
| Venkatesh, M | 1 |
| Mukherjee, S | 1 |
| Wang, H | 1 |
| Li, H | 1 |
| Sun, K | 1 |
| Benechet, AP | 1 |
| Qiu, Z | 1 |
| Maher, L | 1 |
| Redinbo, MR | 1 |
| Phillips, RS | 1 |
| Fleet, JC | 1 |
| Kortagere, S | 1 |
| Mukherjee, P | 1 |
| Fasano, A | 1 |
| Le Ven, J | 1 |
| Nicholson, JK | 1 |
| Dumas, ME | 1 |
| Khanna, KM | 1 |
| Mani, S | 1 |
| Rothhammer, V | 1 |
| Mascanfroni, ID | 1 |
| Bunse, L | 1 |
| Takenaka, MC | 1 |
| Kenison, JE | 1 |
| Mayo, L | 1 |
| Chao, CC | 1 |
| Patel, B | 1 |
| Yan, R | 1 |
| Blain, M | 1 |
| Alvarez, JI | 1 |
| Kébir, H | 1 |
| Anandasabapathy, N | 1 |
| Izquierdo, G | 1 |
| Jung, S | 1 |
| Obholzer, N | 1 |
| Pochet, N | 1 |
| Clish, CB | 1 |
| Prinz, M | 1 |
| Prat, A | 1 |
| Antel, J | 1 |
| Quintana, FJ | 1 |
1 trial available for indolepropionic acid and Inflammation
| Article | Year |
|---|---|
Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Follow-Up Studies; Humans; Incidence; Ind | 2018 |
5 other studies available for indolepropionic acid and Inflammation
| Article | Year |
|---|---|
3-Indolepropionic acid upturned male reproductive function by reducing oxido-inflammatory responses and apoptosis along the hypothalamic-pituitary-gonadal axis of adult rats exposed to chlorpyrifos.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Chlorpyrifos; Epididymis; Hypothalamo-Hypophyseal Syst | 2021 |
Indole-3-Propionic Acid, a Functional Metabolite of
Topics: 3' Untranslated Regions; Animals; Cell Line; Clostridium; Gastrointestinal Microbiome; Gene Expressi | 2021 |
Indolepropionic acid reduces obesity-induced metabolic dysfunction through colonic barrier restoration mediated via tuft cell-derived IL-25.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Fatty Acids, Nonesterified; Glucose; Indoles; In | 2022 |
Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4.
Topics: Adherens Junctions; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Caco-2 Cells; CD3 | 2014 |
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
Topics: Animals; Astrocytes; Case-Control Studies; Cell Proliferation; Central Nervous System; Chemokine CCL | 2016 |